ORIC affiliate files Form 144 to sell 7,000 shares

ORIC Pharmaceuticals filed a Form 144 notice disclosing a proposed sale of Common stock.

Rhea-AI Filing Summary

ORIC Pharmaceuticals filed a Form 144 notice disclosing a proposed sale of Common stock. The filing lists 7,000 Common shares associated with J.P. Morgan Securities LLC and records two stock option exercises of 3,500 shares each dated 08/25/2016 and 07/06/2026. The filing names Nasdaq and includes identifying numbers shown in the excerpt.

Key Figures

Shares listed: 7,000 shares Option exercise (1): 3,500 shares Option exercise (2): 3,500 shares +2 more

5 metrics

Shares listed 7,000 shares Line item alongside J.P. Morgan Securities LLC and Nasdaq

Option exercise (1) 3,500 shares Stock Option Exercise dated 08/25/2016

Option exercise (2) 3,500 shares Stock Option Exercise dated 07/06/2026

Identifier 103517562 Numeric identifier shown on the same line as 07/06/2026

Referenced number 84,000 Numeric value displayed near the 7,000-share entry

Key Terms

Stock Option Exercise, Form 144, Issuer

3 terms

Stock Option Exercise financial

"Stock Option Exercise | Issuer | 3,500 | 08/25/2016"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer financial

"Stock Option Exercise | Issuer | | | 3,500"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ORIC's Form 144 disclose about shares to be sold?

The Form 144 discloses 7,000 Common shares linked to J.P. Morgan Securities LLC. It lists two stock option exercises of 3,500 shares each on 08/25/2016 and 07/06/2026, as shown in the excerpt.

Who is listed as the broker or broker-dealer on the Form 144 for ORIC?

The filing names J.P. Morgan Securities LLC at 270 Park Avenue, New York. That broker-dealer is listed alongside the Common shares and the 7,000 quantity in the excerpt.

Do the Form 144 entries show the sale method or proceeds for ORIC shares?

The excerpt lists Stock Option Exercise and labels the transactions as Issuer and Cash, but it does not state sale proceeds or detailed distribution methods in the provided text.

What dates are tied to the securities and transactions in ORIC's Form 144 excerpt?

Dates shown include 08/25/2016 for a stock option exercise and 07/06/2026 as an entry date; both dates appear next to 3,500-share entries in the excerpt.

Are identifying or registration numbers included in ORIC's Form 144 excerpt?

Yes; the excerpt shows numeric identifiers including 84,000 and 103517562 alongside the 7,000-share line and the 07/06/2026 date as presented.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 04:27 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001584759
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oric Pharmaceuticals, Inc.
SEC File Number	001-39269
Address of Issuer	240 E. Grand Ave 2nd Floor San Francisco CALIFORNIA 94080
Phone	6503885600
Name of Person for Whose Account the Securities are To Be Sold	Richard A, Heyman
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	7000	84000	103517562	07/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2016	Stock Option Exercise	Issuer			3500	08/25/2016	Cash
Common	07/06/2026	Stock Option Exercise	Issuer			3500	07/06/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Some of the sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of this filing.
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Richard A. Heyman.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)